Global Blood-Grouping Lyophilized Reagent Market Growth 2025-2031

The global Blood-Grouping Lyophilized Reagent market size is predicted to grow from US$ 2062 million in 2025 to US$ 3503 million in 2031; it is expected to grow at a CAGR of 9.2% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Blood-Grouping Lyophilized Reagent is a freeze-dried biological reagent specifically formulated for the accurate determination of blood groups (e.g., ABO and Rh systems) in human blood samples. Through standardized immunological reactions (e.g., agglutination), it identifies antigen-antibody interactions on red blood cells, enabling reliable blood typing for transfusion compatibility, medical diagnostics, and research applications.

United States market for Blood-Grouping Lyophilized Reagent is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Blood-Grouping Lyophilized Reagent is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Blood-Grouping Lyophilized Reagent is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Blood-Grouping Lyophilized Reagent players cover Beckman Coulter, Merck KGaA, Bio-Rad Laboratories, BAG Diagnostics GmbH, Thermo Fisher Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Blood-Grouping Lyophilized Reagent Industry Forecast” looks at past sales and reviews total world Blood-Grouping Lyophilized Reagent sales in 2024, providing a comprehensive analysis by region and market sector of projected Blood-Grouping Lyophilized Reagent sales for 2025 through 2031. With Blood-Grouping Lyophilized Reagent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood-Grouping Lyophilized Reagent industry.

This Insight Report provides a comprehensive analysis of the global Blood-Grouping Lyophilized Reagent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood-Grouping Lyophilized Reagent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood-Grouping Lyophilized Reagent market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood-Grouping Lyophilized Reagent and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood-Grouping Lyophilized Reagent.

This report presents a comprehensive overview, market shares, and growth opportunities of Blood-Grouping Lyophilized Reagent market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Serology
Microplate Agglutination Method
Microcolumn Gel Method
Microfluidic Testing
Other Techniques

Segmentation by Application:
Hospitals and Ambulatory Surgical Centers
Clinical Laboratories
Blood Banks
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Beckman Coulter
Merck KGaA
Bio-Rad Laboratories
BAG Diagnostics GmbH
Thermo Fisher Scientific
Lorne Laboratories Limited
Atlas Medical GmbH
Prestige Diagnostics
Tulip Diagnostics (P) Ltd
Torax Biosciences Limited
Grifols
Essange Reagents
QuidelOrtho Corporation
Essange Reagents
Meril Life Sciences Pvt. Ltd.
ARKRAY

Key Questions Addressed in this Report

What is the 10-year outlook for the global Blood-Grouping Lyophilized Reagent market?

What factors are driving Blood-Grouping Lyophilized Reagent market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Blood-Grouping Lyophilized Reagent market opportunities vary by end market size?

How does Blood-Grouping Lyophilized Reagent break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.